PubMed · 485455
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
H K Rjosk, R Fahlbusch, K von Werder. 1979-07-20. [Hyperprolactinemia and sterility].. https://pubmed.ncbi.nlm.nih.gov/485455/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
OBJECTIVE: To describe a technique for surgical management of complete obliteration of the endometrial cavity. DESIGN: A report of a series of three patients. SETTING: A university-based hospital. PATIENT(S): Three patients with complete obliteration of the endometrial cavity. INTERVENTION(S): Transfundal scar removal using stents in the fallopian tubes to serve as landmarks. MAIN OUTCOME MEASURE(S): Regular withdrawal bleeding. RESULT(S): Regular menses in all three patients. CONCLUSION(S): The technique described here show promise for establishing uterine cavity integrity in cases of complete endometrial obliteration where there are no landmarks in the uterine cavity.
STUDY OBJECTIVE: To evaluate the prevalence of resumption of menstruation after an interval of amenorrhea in women treated by endometrial ablation and myometrial resection. DESIGN: Retrospective analysis. SETTING: Tertiary care university-affiliated teaching hospital. PATIENTS: One hundred fifty-seven consecutive patients treated for menorrhagia refractory to medical therapy. INTERVENTIONS: Loop resection or rollerball ablation of the endometrium. MEASUREMENTS AND MAIN RESULTS: At 6 to 12 months postoperatively, 50. 6% of patients were amenorrheic and 35.1% had hypomenorrhea. Over follow-up of 13 to 30 months, 45.1% of women became amenorheic and 40.5% had satisfactory hypomenorrhea. Resumption of menstruation after any interval of amenorrhea occurred in 27.2% of amenorheic patients. We observed an increasing trend to resumption of menstruation after rollerball ablation (29.4%) compared with loop resection (26.7%) and after preoperative endometrial suppression with buserelin (37.5%) and leuprolide (27.1%) compared with danazol (12.5%) and goserelin (10.5%). Resumption of menstruation occurred in 44.4% of women who did not have preoperative endometrial suppression. CONCLUSIONS: Our results suggest that resumption of menstruation does occur after a variable interval of amenorrhea following endometrial ablation and myometrial resection. It could potentially be used as a marker of failure of endometrial destruction.
BACKGROUND: The role of amenorrhea induced by chemotherapy in premenopausal women with early breast cancer is very controversial. Analyses by various authors of the effect of drug-induced amenorrhea (DIA) on treatment outcome have yielded conflicting results. In order to gain insight into the role of DIA, we reviewed all published data addressing the issue of DIA as a prognostic factor. METHODS: Computerised and manual searches were conducted of relevant studies published from 1966 to 1995. RESULTS: Thirteen studies involving 3929 patients were selected. In two papers, the prognostic role of DIA was analysed in three and two different groups of patients, respectively. Overall, 16 groups of patients were evaluated. With 12 groups, a higher disease free survival was observed in patients developing DIA compared to those who did not. This difference was statistically significant in eight groups. Data on overall survival, reported in only five studies, indicated that it was always improved in patients who became amenorrheic. CONCLUSIONS: Available data on the role of DIA support its importance as a favorable prognostic factor for early breast cancer patients. However, due to the possible biases of this type of evaluation, this result should be interpreted with caution.